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High-fat meals rich in EPA plus DHA compared with DHA only have
differential effects on postprandial lipemia and plasma 8-isoprostane
F2a concentrations relative to a control high–oleic acid
meal: a randomized controlled trial1–4
Robert Purcell, Sally H Latham, Kathleen M Botham, Wendy L Hall, and Caroline PD Wheeler-Jones
ABSTRACT
Background: Eicosapentaenoic acid (EPA) plus docosahexaenoic
acid (DHA) supplementation has beneficial cardiovascular effects,
but postprandial influences of these individual fatty acids are
unclear.
Objectives: The primary objective was to determine the vascular
effects of EPA + DHA compared with DHA only during postprandial
lipemia relative to control high–oleic acid meals; the secondary
objective was to characterize the effects of linoleic acid–enriched
high-fat meals relative to the control meal.
Design: We conducted a randomized, controlled, double-blind
crossover trial of 4 high-fat (75-g) meals containing 1) high–oleic
acid sunflower oil (HOS; control), 2) HOS + fish oil (FO; 5 g EPA
and DHA), 3) HOS + algal oil (AO; 5 g DHA), and 4) high–linoleic
acid sunflower oil (HLS) in 16 healthy men (aged 35–70 y) with
higher than optimal fasting triacylglycerol concentrations (mean 6
SD triacylglycerol, 1.9 6 0.5 mmol/L).
Results: Elevations in triacylglycerol concentration relative to base-
line were slightly reduced after FO and HLS compared with the
HOS control (P , 0.05). The characteristic decrease from baseline
in plasma nonesterified fatty acids after a mixed meal was in-
hibited after AO (D 0–3 h, P , 0.05). HLS increased the augmen-
tation index compared with the other test meals (P , 0.05),
although the digital volume pulse–reflection index was not signif-
icantly different. Plasma 8-isoprostane F2a analysis revealed op-
posing effects of FO (increased) and AO (reduced) compared with
the control (P , 0.05). No differences in nitric oxide metabolites
were observed.
Conclusions: These data show differential postprandial 8-isoprostane
F2a responses to high-fat meals containing EPA + DHA–rich fish
oil compared with DHA-rich AO, but these differences were not
associated with consistent effects on postprandial vascular function
or lipemia. More detailed analyses of polyunsaturated fatty acid–
derived lipid mediators are required to determine possible divergent
functional effects of single meals rich in either DHA or EPA. This
trial was registered at clinicaltrials.gov as NCT01618071. Am J
Clin Nutr 2014;100:1019–28.
INTRODUCTION
Long-chain (LC)5 n23 PUFAs—namely, EPA (20:5n23) and
DHA (22:6n23)—are abundant in oily fish, the main dietary
source of preformed EPA and DHA. However, alternative
sources are increasingly being considered as important dietary
contributors of LC n23 PUFAs for the future, including marine
microalgae, krill, and genetically modified crops (1). Pro-
spective cohort studies indicate that LC n23 PUFA or fish
intakes are associated with a lowered risk of cardiovascular
disease (CVD) mortality (2), whereas evidence from random-
ized controlled trials is less coherent (3–5). Heterogeneous
outcomes from LC n23 PUFA trials may be influenced by
a number of factors, including background diet (6), dose, med-
ication (eg, statins) (7), concomitant risk factors, and varying
ratios of EPA to DHA in fish-oil supplements. There is little
information regarding the individual effects of EPA and DHA
(8), and this knowledge is urgently required now that separate
algal sources of DHA and EPA are commercially available or
under development.
An exaggerated postprandial triglyceride-rich lipoprotein re-
sponse, including chylomicrons and their remnants, is considered
a key factor in the development of atherosclerosis (9). Post-
prandial inflammation involving endothelial cell and leukocyte
activation is likely to contribute to this (10); we, as well as others,
have suggested potential dependence on chylomicron/chylomicron
remnant fatty acid composition (11, 12). Postprandial impairment
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in endothelial function after high-fat meals has been widely
reported (13, 14) and may be linked to oxidative stress (15), with
implications for the atherogenic potential of habitual con-
sumption of high-fat foods. The relative postprandial effects of
different unsaturated fatty acid–rich meals (MUFA compared
with n26 PUFA) require clarification (13, 14). Evidence is also
accumulating that supplementation with EPA as opposed to
DHA, in chronic dietary interventions, is likely to exert differ-
ential effects on outcomes such as plasma triacylglycerol con-
centrations, arterial stiffness, lipoprotein particle size, blood
pressure, and heart rate (16), but associated mechanisms are
unclear.
The primary objective of this acute randomized, controlled,
double-blind crossover trial was to determine whether there were
divergent effects of EPA + DHA–rich (fish oil; FO), DHA-rich
(algal oil; AO), and linoleic acid (n26 PUFA)–rich (high–
linoleic acid sunflower oil; HLS) meals on vascular function and
oxidative stress compared with a control MUFA-rich (high–oleic
acid sunflower oil; HOS) meal. HOS was allocated as the control
because it has been shown to induce pronounced postprandial
lipemia and impair endothelial function (17). It was hypothe-
sized that high-fat meals containing FO and AO would result in
improved vascular and oxidative stress responses during post-
prandial lipemia, whereas the response to HLS would be un-
changed relative to the control (HOS) in men.
SUBJECTS AND METHODS
This single-center dietary intervention study was conducted at
King’s College London, United Kingdom, between June and
October 2012. Ethical approval was obtained from the National
Research Ethics Service Committee London – Dulwich (REC
reference: 11/LO/0116). All participants signed an informed con-
sent form before any measurements were taken. This study was
conducted in accordance with the principles outlined in the Dec-
laration of Helsinki and has been registered with clinicaltrials.gov
(NCT01618071).
Subjects
Nonsmoking men aged 35–70 y were recruited by internal
e-mail at King’s College London and through advertisement in
free newspapers distributed London-wide. Respondents were
initially interviewed by telephone to assess eligibility and then
invited to attend a screening visit in the fasting state for mea-
surement of height, weight, waist circumference, and seated
blood pressure, and a blood sample was taken for liver function
tests, hematology, glucose, and lipid profile. Inclusion criteria
were as follows: healthy, male, aged 35–70 y, nonsmoking, and
plasma triacylglycerol concentrations .1.2 mmol/L. Exclusion
criteria were a reported history of CVD, cancer, kidney, liver, or
bowel disease; presence of a gastrointestinal disorder or use of
drugs likely to alter gastrointestinal motility; history of sub-
stance abuse or alcoholism; current self-reported alcohol intake
.224 g/wk; allergy or intolerance to any component of test
meals; unwillingness to restrict consumption of oily fish/FO
supplements; weight change .3 kg in previous 2 mo; BMI (in
kg/m2) ,20 or .35; fasting blood cholesterol .7.8 mmol/L;
and current use of lipid-lowering medication. Participants were
randomly allocated to treatment order after confirmation of
eligibility by using the random-number generator function
RANDBETWEEN (0,100) in Microsoft Excel software.
Test meal composition
Each participant consumed an isoenergetic high-fat meal
(4.6 MJ, 75 g fat, 92.8 g carbohydrate, and 14.4 g protein) on 4
separate study visits, containing highMUFA oil (reference meal),
high n26 PUFA oil, high MUFA oil with 5 g EPA + DHA, or
high MUFA oil with 5 g DHA only (Table 1). The test meal
consisted of a muffin (3.7 MJ, 64.5 g fat, 68 g carbohydrate, and
7.6 g protein) and a strawberry-flavored (Nesquik; Nestle´)
milkshake (0.9 MJ, 10.5 g fat, 24.8 g carbohydrate, and 6.8 g
protein). The reference test meal (HOS meal) contained high
MUFA fat in the form of HOS (ADM Trading Ltd), which was
added to the muffin (64.5 g) and the milkshake (10.5 g). The
high n26 PUFA meal (HLS meal) contained HLS (ADM
Trading Ltd) added in the same quantities. The high n23 PUFA
(EPA + DHA) meal (FO meal) contained HOS (64.5 g in the
muffin) and 6.7 g of a purified fish oil [Incromega TG4030-
(LK); Croda Europe Ltd] to provide 5 g EPA + DHA (equivalent
to that derived from approximately 400 g cooked salmon), plus
3.8 g HOS in the milkshake (10.5 g total oils). The high n23
PUFA (DHA-only) meal (AO meal) contained HOS (64.5 g in
the muffin) and 10.5 g of a marine micro–algal oil extracted
from Crypthecodinium cohnii (DHASCO; Martek Biosciences
Corporation) to provide 5 g DHA in the milkshake. The meals
were labeled with a concealed code by a technician at King’s
College London who was not involved in the study or its anal-
ysis, and all study researchers and participants were blinded to
the identity of each test meal.
Study protocol
A randomized, controlled, double-blind crossover study design
was used, in which participants attended the metabolic research
unit at King’s College London on 4 separate occasions to con-
sume each meal, with each study day being at least 1 wk apart.
Participants were asked to avoid the consumption of oily fish
and fatty acid supplementation during the 2 wk before and
throughout their study period. Participants were asked to refrain
from consuming high-fat foods, caffeine, alcohol, and nitrate-rich
foods such as green leafy vegetables and beetroot 24 h before
each study day because these dietary components may have
TABLE 1
Test meal fatty acid composition1
Fatty acids HOS HLS FO AO
EPA (20:5n23) 0 0 3.1 0
DHA (22:6n23) 0 0 1.9 5
Docosapentaenoic acid (22:5n23) 0 0 0.4 0.1
Oleic acid (18:1n29) 61.7 18.8 56.2 53.1
Linoleic acid (18:2n26) 6.2 47.2 5.6 5.3
Myristic acid (14:0) 0 0 0.2 7.3
Palmitic acid (16:0) 2.9 4.9 0.3 6.3
Palmitoleic acid (16:1) 0 0 0.6 1.4
1All values are grams. Fatty acid compositions of the oils were mea-
sured by using gas chromatography. AO, algal oil meal; FO, fish-oil meal;
HLS, high–linoleic acid sunflower oil meal; HOS, high–oleic acid sunflower
oil meal.
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affected postprandial lipemic response, vascular function, or
nitric oxide metabolite measurements. In addition, subjects were
also asked to avoid strenuous exercise 24 h before each study day,
to consume a specified commercially available low-fat ready
meal (,10 g fat) for their evening meal, and to fast from 2030,
consuming only low-nitrate water (Buxton; Nestle´) thereafter.
Participants reported to the metabolic research unit between
0800 h and 1000 h in a fasted state. On arrival, they were weighed
and then rested in a supine position for 10 min. Baseline digital
volume pulse (DVP) and Arteriograph24 (TensioMed) mea-
surements were recorded, and then an indwelling venous can-
nula was fitted by a trained clinician and baseline blood samples
taken for plasma triacylglycerol, cholesterol, nonesterified fatty
acids (NEFAs), glucose, fatty acid, nitric oxide metabolites, and
8-isoprostane F2a analysis. The test meal was consumed within
10 min, and subsequently blood was taken every hour for mea-
surement of triacylglycerol, cholesterol, NEFAs, glucose con-
centrations, and total fatty acid profile analysis. Blood samples
were also taken at 2, 4, and 6 h for nitric oxide metabolite and
8-isoprostane F2a analysis.
Vascular measurements
Blood pressure, arterial stiffness, and changes in the reflected
pulse wave were measured by using 2 methods: 1) an oscillo-
metric, occlusive upper-arm cuff device called the Arterio-
graph24 (TensioMed), which can be used under ambulatory
conditions to indirectly calculate parameters such as aortic pulse
wave velocity, augmentation index [AIx; central and peripheral
(AIxao and AIxbr, respectively)], central systolic blood pressure,
and brachial systolic and diastolic blood pressure (18, 19) and 2)
DVP by photoplethysmography (PulseTrace; Micro Medical
Ltd) to calculate the stiffness index (DVP-SI, m/s) and reflection
index (DVP-RI, %). DVP-SI is related to large-artery stiffness
and correlates closely with large-artery pulse wave velocity (20).
DVP-RI is more strongly related to vascular tone of small ar-
teries and is markedly sensitive to drugs influencing vasomotor
tone (21). DVP was measured in a warm, quiet environment
with the participant in a supine position after a 10-min rest. All
DVP measurements were taken in triplicate and the average
value calculated for each time point. DVP measurements were
recorded 2, 4, and 6 h after consumption of the high-fat meal.
The intraobserver coefficient of variance for within-subject
measurements on 6 successive days in our laboratory was
4.9% for DVP-RI and 3.8% for DVP-SI. Participants were fitted
with an Arteriograph24 cuff to wear for the duration of each
study day, with measurements being recorded every 30 min,
during which subjects were asked to remain still and to avoid
talking. Within-subject Arteriograph24 measurements made 1–4 wk
apart at baseline in this study (n = 15) correlated significantly
for peripheral, central, and mean arterial blood pressure (r =
0.7–1.0, P = 0.005–,0.00001) and peripheral and central
AIx (r = 0.4–0.9, P = 0.00005–0.09), demonstrating good
repeatability.
Plasma lipids, glucose, nitric oxide metabolites, and
8-isoprostane F2a
Blood samples for total plasma fatty acid composition, lipo-
protein fraction isolation, plasma triacylglycerol, cholesterol,
NEFAs, and nitrite/nitric oxide metabolite (NOx) concentrations
were collected into EDTA-coated tubes and centrifuged at
1500 3 g for 15 min at 48C. Blood samples for glucose analysis
were collected into fluoride oxalate tubes and centrifuged with
the EDTA-coated tubes. Apart from plasma allocated for lipo-
protein fraction isolation, plasma samples were stored at 2808C
until analysis. Plasma triacylglycerol, cholesterol, NEFAs, and
glucose were measured on an ILab650 automated analyzer
(Instrumentation Laboratory) with commercially available en-
zymatic kits (Instrumentation Laboratory; WAKO NEFA-HR,
WAKO Chemicals GmbH). Chylomicron and intermediate-
density lipoprotein fractions were analyzed for fatty acid com-
position, triacylglycerol and cholesterol, and applied to cultured
endothelial cells to investigate inflammatory pathways in a se-
ries of experiments to be reported in a separate study (Purcell
et al, unpublished results, 2014).
The fatty acid compositions of plasma and natural oils used in
the study were analyzed by gas chromatography with a one-step
direct transesterification process, a method extensively described
and used in the literature, allowing measurement of both lipid-
bound and free fatty acids (22–24).
The most reliable measure of oxidative stress in vivo is
8-isoprostane F2a, which is produced by the free radical–catalyzed
peroxidation of arachidonic acid (25). Here, plasma 8-isoprostane
F2a concentrations were measured by gas chromatography/mass
spectroscopy after immunoaffinity separation, a method that is
both highly sensitive and accurate (26) and has been described
previously (24). Our assay is highly specific to 8-isoprostane
F2a and does not measure F3 or F4 isoprostanes derived from EPA
or DHA. The immunoaffinity columns (Cayman Chemical) used
for this analysis have very little binding to the 8-isoprostane
F2a isomer prostaglandin F2a (.0.8%). Furthermore, prostaglan-
din F2a and 8-isoprostane F2a are separated by the gas chroma-
tograph in our setup (data not shown); thus, any contamination
with PGF2a does not interfere with measurement of 8-isoprostane
F2a concentrations.
Plasma total NOx and nitrite were measured by ozone
chemiluminescence as described previously (27). Plasma nitrate
was calculated by subtracting the plasma nitrite concentration
from plasma NOx.
Statistical analysis
To detect a 6.5% difference between test meals in peripheral
AIx with an 80% power and a significance level of 0.01 (2-tailed),
we needed 16 subjects. This difference was based on previous
studies measuring pulse wave forms within our laboratory. In
addition, statistical power calculations carried out on data from
a similar study in our laboratory, in middle-aged men with
slightly raised fasting triacylglycerol concentrations, determined
that a sample size of 16 would have 80% power to detect
a difference between means of 0.67 mmol/L in triacylglycerol
concentrations at a significance level of 0.01. Data were tested
for normality and log-transformed where necessary. Two-factor
repeated-measures ANOVA (factors were treatment and time)
was used to test for significant treatment3 time interactions and
effects of time, as well as for significant treatment effects on
change from baseline values. Where an overall treatment effect
or treatment 3 time interaction was shown, Bonferroni post hoc
tests were carried out to test which meals were different from the
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control meal (HOS). If data were not deemed normally dis-
tributed, they were log-transformed to normalize and then the
same analysis was applied. Data analysis and graphs were pro-
duced by GraphPad Prism version 6.01 (GraphPad Software).
RESULTS
Sixteen subjects completed each of the 4 intervention arms
(Figure 1). Characteristics of completing participants measured
at the screening visit are shown in Table 2. No adverse effects
were reported. Participants were mainly middle-aged (11 were
aged $45 y), and 10 were overweight. Half met the In-
ternational Diabetes Federation cutoff for abdominal adiposity
(ie, waist circumference .94 cm), and 13 of 16 had fasting
triacylglycerol concentrations .1.5 mmol/L.
Postprandial lipids
Postprandial total plasma fatty acid composition reflected meal
fatty acid composition (Figure 2). FO resulted in a marked in-
crease in both EPA and DHA plasma composition and also
moderately increased the proportion of the fatty acids that was
docosapentaenoic acid. AO induced a marked increase in DHA
only, and there was a large increase in the proportion of linoleic
acid after HLS (all treatment effects P , 0.0001). Regarding
total LC n23 PUFA (EPA + DHA), there were changes of
174% and 106% at 6 h after FO and AO, respectively.
All 4 meals induced a marked increase in postprandial tri-
acylglycerol concentrations (time effect, P, 0.0001), with HOS
(control) inducing the greatest increase in plasma triacylglycerol
concentrations, peaking at 5 h (Figure 3A). There was a re-
duction in postprandial triglyceridemia after FO and HLS rela-
tive to the control HOS meal [treatment effect on changes from
baseline (0 h) to 6 h, P , 0.05], with post hoc comparisons
showing the differences to be statistically significant at 4, 5, and
6 h, whereas AO had similar effects to HOS (post hoc statistical
data shown in Figure 3 legend). Plasma NEFA concentrations
decreased 1–2 h after test meals (time effect, P , 0.0001;
Figure 3B). The magnitude of the decrease in NEFA con-
centrations was significantly reduced after the AO meal
(treatment effect on changes from baseline 0–3 h, P , 0.05),
with statistically significantly higher plasma NEFA concen-
trations evident at 1, 2, and 3 h compared with HOS. FO had no
effect on plasma NEFAs relative to the HOS meal. Baseline
triacylglycerol and NEFA concentrations were not different
between groups (see Supplementary Table 1 under “Supplemental
data” in the online issue). There were no differences in post-
prandial glucose or cholesterol concentrations between groups
(data not shown).
Vascular measurements
There were statistically significant time effects for pulse wave
reflection (AIxao and AIxbr; P , 0.001), with the greatest re-
duction evident at the 2-h time point (Figure 4). Comparing the
different test meals, at 2 h, the greatest decreases in pulse wave
reflection were seen with FO and AO for both measures, al-
though there was only a statistically significant overall treatment
effect for AIxao (P , 0.05). The postprandial reduction in AIxao
observed after HOS, FO, and AO was initially diminished
after HLS, and after 3 h, no lowering effect was detected.
There were no statistically significant differences in heart rate,
central systolic blood pressure, or mean arterial pressure after
the different test meals. There were no treatment differences
observed in peripheral systolic or diastolic blood pressure, DVP-
SI or DVP-RI, or plasma NOx (Table 3).
8-Isoprostane F2a
There was a statistically significant time effect for plasma
8-isoprostane F2a concentrations (P, 0.05), reflecting postprandial
increases after HOS, HLS, and FO, although no increase was
observed after AO (Figure 5). A significant treatment 3 time
interaction (P , 0.05) for data unadjusted for baseline values
reflected reduced concentrations at 6 h after AO and increased
concentrations following FO relative to HOS (post hoc statistics
shown in the Figure 5 legend). No differences in postprandial
FIGURE 1. Consolidated Standards of Reporting Trials flow diagram.
AIxao, central augmentation index; AIxbr, peripheral augmentation index;
Arteriograph, Arteriograph 24 upper-arm cuff device (TensioMed); DBPbr,
peripheral diastolic blood pressure; SBPao, central systolic blood pressure;
SBPbr, peripheral systolic blood pressure.
TABLE 2
Participant characteristics at initial screening visit1
Characteristic Value
Age (y) 49.9 6 11.4
Weight (kg) 82.8 6 14.7
Height (m) 1.74 6 0.06
BMI (kg/m2) 27.3 6 3.9
Body fat composition (%) 23.6 6 7.6
Waist circumference (cm) 99 6 10
Systolic blood pressure (mm Hg) 122 6 22
Diastolic blood pressure (mm Hg) 80 6 9
Heart rate (beats/min) 67 6 9
Plasma triglycerides (mmol/L) 1.88 6 0.51
Total plasma cholesterol (mmol/L) 5.26 6 0.66
Plasma LDL cholesterol (mmol/L) 3.37 6 0.82
Plasma HDL cholesterol (mmol/L) 1.33 6 0.40
Plasma glucose (mmol/L) 5.46 6 0.40
1Values are means 6 SDs. n = 16 participants.
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8-isoprostane F2a concentrations were observed between HOS
and HLS.
DISCUSSION
This study investigated the effects of consuming high-fat
meals of varying unsaturated fatty acid composition to test the
hypothesis that meals enriched with LC n23 PUFAs—either fish
oil (EPA and DHA) or algal oil (DHA only)—result in more
favorable vascular and oxidative stress responses postprandially
compared with a control high-MUFA meal. In contrast, the
postprandial response to a meal enriched with n26 PUFAs was
not expected to differ from the response to the control high-
MUFA meal. High–oleic acid sunflower oil was used as the
comparator because it has been shown to induce a pronounced
lipemia and to impair flow-mediated dilatation (15, 17, 28),
a gold-standard measure of endothelium-dependent vasodilation
in the brachial artery. As expected, the fatty acid composition
of the plasma was altered postprandially to reflect that of the
meal composition (Figure 2). We investigated an older male
population who had high-normal concentrations of fasting tri-
acylglycerol and were therefore likely to have a more pro-
nounced postprandial lipemia (29). Part of the broader aim
of this project was complementary in vitro research using
triglyceride-rich lipoprotein fractions isolated postprandially from
study participants (results unpublished). Therefore, a greater fat
load (75 g) to that previously used by our group (50 g) was
administered to ensure a pronounced lipemic response and op-
timum harvesting of postprandial lipoproteins, and this was well
tolerated by participants. Postprandial plasma triacylglycerol
concentrations were marginally reduced after FO, but not
AO, relative to the HOS reference meal. We have previously
reported in younger subjects that purified EPA-rich FO did not
reduce postprandial triacylglycerol 6 h after a high-fat meal
(24, 30). Although it is well established that chronic supple-
mentation with FO reduces postprandial lipemia (31–33), most
studies have not shown any reduction in relative postpran-
dial triacylglycerol response after a single FO test meal
FIGURE 2. Total plasma EPA (A), DHA (B), DPA (C), EPA + DHA (D), oleic (E), and linoleic (F) fatty acids after the 4 high-fat meals. Values are
expressed as means (6SEMs) as assessed by gas chromatography; n = 16. Each fatty acid shown changed significantly with time (P , 0.0001) and differed
according to treatment (P , 0.0001), and there was a treatment 3 time interaction (P , 0.0001) as analyzed by 2-factor repeated-measures ANOVA. AO,
algal oil meal; DPA, docosapentaenoic acid; FO, fish-oil meal; HLS, high–linoleic acid sunflower oil meal; HOS, high–oleic acid sunflower oil meal.
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(11, 14, 30, 34–36) apart from those that used larger doses of
EPA + DHA (37, 38).
Apart from its effects on plasma triacylglycerol concentra-
tions, FO had no other effects on plasma lipids postprandially
compared with the control HOS meal. However, AO clearly
influenced circulating NEFA concentrations. Postprandially,
stored triacylglycerol lipolysis is suppressed because of the in-
hibitory action of insulin on hormone-sensitive lipase so that
plasma NEFA concentrations are reduced (39, 40). Here, the
characteristic decrease in plasma NEFAs was not as marked
after the AO meal relative to the HOS reference meal. Although
purely speculative at this stage, potential mechanisms may
involve an increase in spillover fatty acids escaping from
lipoprotein lipase action on chylomicron triacylglycerol or re-
duced insulin secretion/action, resulting in diminished suppres-
sion of adipocyte triacylglycerol lipolysis. The role of insulin in
the diminished suppression of circulating NEFA concentrations
after AO was not explored in the current study because more
frequent blood sampling time points would be necessary to ac-
curately measure plasma insulin concentrations during the early
postprandial period. In contrast, the NEFA response to FO was
similar to that seen with HOS. A greater reduction in NEFAs after
an FO compared with a control meal has been reported pre-
viously, but a lower EPA-to-DHA ratio and lower total fat content
were used in the test meal compared with the current study (41).
To summarize the findings regarding postprandial lipids, subtle
differences in triacylglycerol response to FO and AO are likely to
be of little clinical importance regarding the therapeutic use of
prescribed n–3 fatty acid products, and there was a clear in-
hibition of the early postprandial suppression of circulating
NEFA concentrations after AO relative to HOS control. Mech-
anisms for this latter effect are unclear.
Other studies have demonstrated that EPA alone (24) and in
combination with DHA (as fish oil) (11, 42, 43) enhances va-
sodilation and vascular function in the postprandial state. In this
study, there was no effect of either LC n23 PUFAmeal on AIxao,
AIxbr, DVP-SI, or DVP-RI relative to the control, which con-
trasts with Chong et al (41), who reported a marginally en-
hanced postprandial reduction in AIx and DVP-SI after FO. HLS
FIGURE 3. Change in postprandial plasma TAG (A) and NEFAs (B) after
the 4 high-fat meals. Values for plasma TAG concentrations are mean
(6SEM) changes in natural log-transformed data relative to fasting baseline
values; n = 16. Values for plasma NEFA concentrations are mean (6SEM)
changes in relation to fasting baseline values. Results were analyzed by
2-factor repeated measures ANOVA with Bonferroni post hoc analysis to
determine which meals differed from control and at which time points. Both
NEFAs and TAG changed with time (P , 0.0001) and differed according to
treatment (P , 0.05), and there was a treatment 3 time interaction (P ,
0.05). There was a reduction in (Ln)TAG after FO and HLS relative to HOS
at 4, 5, and 6 h, whereas AO had no effect relative to HOS. NEFA concen-
trations were suppressed relative to baseline after all 4 meals, but AO di-
minished the reduction in NEFAs at 1, 2, and 3 h relative to HOS. FO
compared with HOS: *P , 0.05, **P , 0.01; HLS compared with HOS:
#P , 0.05, ##P , 0.01, ###P , 0.001; AO compared with HOS: $P , 0.05,
$$P , 0.01. AO, algal oil meal; FO, fish-oil meal; HLS, high–linoleic acid
sunflower oil meal; HOS, high–oleic acid sunflower oil meal; NEFA,
nonesterified fatty acid; TAG, triacylglycerol.
FIGURE 4. Change in aortic (A) and brachial (B) AIx after the 4 high-fat
meals. Values are mean (6SEM) changes relative to fasting baseline values
at 1–6 h after test meals; n = 14. Data were analyzed by 2-factor repeated-
measures ANOVAwith a Bonferroni post hoc test to determine which meals
differed from control and at which time points. Both AIxao and AIxbr were
statistically significantly different over time (P , 0.0001). There was a sta-
tistically significant treatment effect with AIxao (P , 0.05), but the effect of
treatment was not significant for AIxbr (P = 0.14). There was no treatment3
time interaction for either AIxao or AIxbr. AIxao, central augmentation index;
AIxbr, peripheral augmentation index; AO, algal oil meal; FO, fish-oil meal;
HLS, high–linoleic acid sunflower oil meal; HOS, high–oleic acid sunflower
oil meal.
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inhibited the reduction in central AIx observed postprandially
relative to HOS, FO, and AO. However, this result should be
interpreted with caution because it is well known that aortic pulse
wave reflection may vary with heart rate independently of
changes in arterial tone. Specifically, a reduction in heart rate
tends to be associated with an increase in central AIx resulting
from the lengthening of systole (44). Therefore, the increase in
AIxao observed here may reflect the trend for a greater reduction
in heart rate after HLS (data not shown, P = 0.09) compared with
control, rather than an increase in arterial stiffness.
Plasma NOx concentrations were reduced after all 4 meals, with
no differences between treatments, and plasma nitrite did not
change after the high-fat meals. In contrast, an improvement in
acetylcholine-induced vasodilation after FO (5.4 g EPA + DHA)
consumption accompanied by increased postprandial nitrite con-
centrations has been reported in a study in healthy men (11). We
used a gas phase chemiluminescence reaction between nitric oxide
and ozone to quantify nitrite and total NOx, which is thought to be
more sensitive than the commercially available kits.
Oxidative stress contributes to the development of CVD (45),
and high concentrations of urinary or plasma F2-isoprostanes,
resulting from nonenzymatic oxidation of arachidonic acid, are
suggested to be nonspecific indicators of CVD (46). Previous
studies demonstrated increased plasma 8-isoprostane F2a con-
centrations after high-fat meals containing oleic acid (15), with
further increases evident when EPAwas incorporated (24). Here,
FO increased 6-h plasma 8-isoprostane F2a relative to the HOS
reference meal. Intriguingly, AO reduced 8-isoprostane F2a
concentrations compared with HOS and FO. This novel finding
suggests that EPA and DHA may have opposing effects on free
radical–induced lipid peroxidation associated with postprandial
lipemia. However, this explanation may be misleading because
the increase in plasma 8-isoprostane F2a after FO is not con-
sistent with the reduced postprandial triacylglycerol response
observed after FO relative to AO, which would be expected to
result in lower levels of oxidative stress. Results presented here
and previously (24) suggest that fish oil (more specifically EPA)
may induce transient increases in nonenzymatic oxidation of
arachidonic acid when consumed with a high-fat meal. Com-
petition between EPA and arachidonic acid for oxidative en-
zymes, such as cyclooxygenases 1 and 2, lipoxygenases, and
cytochrome P450 mono-oxygenases, may lead to a greater
availability of arachidonic acid for nonenzymic oxidation,
leading to increased 8-isoprostane F2a production (47). In the
case of the AO meal, the reduced isoprostane concentrations
might be explained by replacement of arachidonic acid by DHA
in the lipid membrane (48), potentially leading to reduced
substrate availability for 8-isoprostane F2a generation. Further
research, including measurement of EPA- and DHA-derived
isoprostanes, should be carried out to clarify the physiologic
significance of these observations.
Strengths of this research include the design (randomized,
controlled, double-blind crossover trial) and the use of sensitive,
specific techniques to measure study outcomes (eg, plasma
8-isoprostane F2a and NOx). The target population was healthy
but displaying signs of a metabolically “risky” phenotype and
therefore more likely to be discriminatory in terms of the dif-
ferential effects of unsaturated fatty acids. The study is limited
by inclusion of men only, and thus the effects of meal fatty acid
composition cannot be extrapolated to women. Clearer data on
the relative effects of EPA and DHA could be obtained if
a similar study were carried out with pure sources of EPA
compared with DHA, but a pure source of EPA triacylglycerol
was not available when the study commenced. Because of
technical difficulties, we were unable to obtain Arteriograph24
vascular data from 2 of the 16 completing participants, and
therefore the study may have been statistically underpowered for
augmentation index and blood pressure measures.
In summary, the results of this study indicate that high-fat
meals of varying unsaturated fatty acid composition differentially
influence the postprandial metabolic and vascular response.
Although EPA and DHA belong to the same fatty acid class and
have similar structures, it has been reported that they exert
different and often opposite effects on vascular function both in
vitro and in vivo (16). The main novel finding is that postprandial
8-isoprostane F2a production is lower after consumption of
a meal enriched with DHA (of algal origin), whereas an FO
meal (EPA + DHA) has the opposite effect. This implies that
EPA and DHA generate metabolites that exert divergent effects
on oxidative pathways in the vasculature (49) and opens up an
important line of investigation into potential mechanisms me-
diating the vasculo-protective properties of LC n23 PUFAs
during the postprandial state. In conclusion, although research
into the clinical significance of the dietary EPA-to-DHA ratio is
in its preliminary stages, the current findings suggest that con-
sumption of DHA-only sources may have distinct effects on
lipid metabolism compared with EPA + DHA sources with
important implications for cardiovascular health.
We thank the subjects for participating in the study, Karen McNeil and
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abetes and Nutritional Sciences, KCL) for assistance with study blinding. In
addition, we extend our thanks to Sarah Berry for input into study design and
FIGURE 5. Change in plasma 8-isoprostane F2a concentrations after
4 high-fat test meals. Values are mean (6SEM) changes relative to fasting
baseline values at 2, 4, and 6 h after test meals; n = 16. Data were analyzed
by 2-factor repeated-measures ANOVA with a Bonferroni post hoc test to
determine which meals differed from control and at which time points. There
were significant effects of time (P , 0.05) and a treatment 3 time interac-
tion for values unadjusted for baseline (P , 0.05), and there was a trend for
a treatment effect on change from baseline data (P = 0.052). Mean values
after FO were increased relative to HOS and, after AO, were decreased
relative to HOS. FO compared with HOS: *P , 0.05; AO compared with
HOS: $P , 0.05. AO, algal oil meal; FO, fish-oil meal; HLS, high–linoleic
acid sunflower oil meal; HOS, high–oleic acid sunflower oil meal.
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